{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:32:43Z","timestamp":1790685163025,"version":"4.1.0"},"reference-count":285,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["18013"],"award-info":[{"award-number":["18013"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20614"],"award-info":[{"award-number":["20614"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R21CA194679-01"],"award-info":[{"award-number":["1R21CA194679-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01823","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T04:34:11Z","timestamp":1534221251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu"],"prefix":"10.3389","volume":"9","author":[{"given":"Michela","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mirandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Chiriva-Internati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Platonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.biopha.2017.11.126","article-title":"Recent advances in cancer immunology and immunology-based anticancer therapies","volume":"96","author":"Kumar","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fonc.2014.00345","article-title":"Non-canonical Notch signaling in cancer and immunity","volume":"4","author":"Ayaz","year":"2014","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/gcc.22264","article-title":"PI3K\/AKT signaling inhibits NOTCH1 lysosome-mediated degradation","volume":"54","author":"Platonova","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1016\/S0960-9822(01)00679-0","article-title":"Protein degradation: four E3s for the Notch pathway","volume":"12","author":"Lai","year":"2002","journal-title":"Curr Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/1381612822666161006160524","article-title":"Targeting Notch as a therapeutic approach for human malignancies","volume":"23","author":"Platonova","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.4049\/jimmunol.180.5.2796","article-title":"Notch1 signaling and regulatory T cell function","volume":"180","author":"Asano","year":"2008","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI26490","article-title":"Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-\u03b2","volume":"116","author":"Ostroukhova","year":"2006","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/0008-5472.CAN-13-3118","article-title":"Tumor-infiltrating myeloid cells activate Dll4\/Notch\/TGF-\u03b2 signaling to drive malignant progression","volume":"74","author":"Ohnuki","year":"2014","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging Notch signaling in bone cells","volume":"19","author":"Sethi","year":"2011","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12957-015-0529-2","article-title":"Interleukin-6 and pro inflammatory status in the breast tumor microenvironment","volume":"13","author":"Sanguinetti","year":"2015","journal-title":"World J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1158\/0008-5472.CAN-15-2528","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL-6\/STAT3 and NO\/NOTCH cross-talk signaling","volume":"76","author":"Peng","year":"2016","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/leu.2013.27","article-title":"Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4\/SDF-1","volume":"27","author":"Mirandola","year":"2013","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11283","DOI":"10.18632\/oncotarget.2207","article-title":"Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4\/CXCL12 axis and promote their polarization toward the M2 phenotype","volume":"5","author":"Beider","year":"2014","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biocel.2015.07.015","article-title":"Notch pathway promotes ovarian cancer growth and migration via CXCR4\/SDF1alpha chemokine system","volume":"66","author":"Chiaramonte","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.4049\/jimmunol.1400201","article-title":"CXCL12\/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells","volume":"193","author":"Gil","year":"2014","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 axis in tumor immunotherapy","volume":"24","author":"Zhou","year":"2017","journal-title":"Curr Med Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/eji.201445346","article-title":"Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway","volume":"45","author":"Neumann","year":"2015","journal-title":"Eur J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1158\/0008-5472.CAN-15-2019","article-title":"Forced activation of Notch in macrophages represses tumor growth by upregulating miR-125a and disabling tumor-associated macrophages","volume":"76","author":"Zhao","year":"2016","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","article-title":"Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1139\/cjpp-2016-0319","article-title":"Primary human monocytes differentiate into M2 macrophages and involve Notch-1 pathway","volume":"95","author":"Singla","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1073\/pnas.0712102105","article-title":"Notch regulates IL-10 production by T helper 1 cells","volume":"105","author":"Rutz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4049\/jimmunol.0903152","article-title":"Cutting edge: plasmacytoid dendritic cells induce IL-10 production in T cells via the delta-like-4\/Notch axis","volume":"184","author":"Kassner","year":"2010","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-3083.2011.02541.x","article-title":"Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells","volume":"74","author":"Sauma","year":"2011","journal-title":"Scand J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.immuni.2007.04.018","article-title":"Notch directly regulates Gata3 expression during T helper 2 cell differentiation","volume":"27","author":"Fang","year":"2007","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1182\/blood-2003-04-1034","article-title":"Notch signaling is necessary but not sufficient for differentiation of dendritic cells","volume":"102","author":"Cheng","year":"2003","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12964-017-0214-x","article-title":"Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis","volume":"16","author":"Pagie","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1182\/blood-2011-02-334995","article-title":"Notch-Hes1 pathway is required for the development of IL-17-producing gammadelta T cells","volume":"118","author":"Shibata","year":"2011","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.4049\/jimmunol.1300369","article-title":"Involvement of Notch in activation and effector functions of \u03b3\u03b4 T cells","volume":"192","author":"Gogoi","year":"2014","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"110426","DOI":"10.18632\/oncotarget.22786","article-title":"Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/2159-8290.CD-17-0037","article-title":"Notch shapes the innate immunophenotype in breast cancer","volume":"7","author":"Shen","year":"2017","journal-title":"Cancer Discov"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1334744","DOI":"10.1080\/2162402X.2017.1334744","article-title":"Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1beta in tumor-associated macrophages","volume":"6","author":"Kersten","year":"2017","journal-title":"Oncoimmunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1172\/JCI78782","article-title":"F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner","volume":"125","author":"Yumimoto","year":"2015","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.4049\/jimmunol.169.8.4273","article-title":"The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells","volume":"169","author":"Weijzen","year":"2002","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1073\/pnas.0709919105","article-title":"Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction","volume":"105","author":"Kijima","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ni.1649","article-title":"Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity","volume":"9","author":"Maekawa","year":"2008","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.4049\/jimmunol.171.6.3019","article-title":"TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells","volume":"171","author":"Palaga","year":"2003","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1002560","DOI":"10.1371\/journal.ppat.1002560","article-title":"Redundant Notch1 and Notch2 signaling is necessary for IFNgamma secretion by T helper 1 cells during infection with Leishmania major","volume":"8","author":"Auderset","year":"2012","journal-title":"PLoS Pathog"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1158\/0008-5472.CAN-10-4366","article-title":"Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth","volume":"71","author":"Huang","year":"2011","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/156800906778742460","article-title":"TGF beta inhibition for cancer therapy","volume":"6","author":"Saunier","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"B41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2966-5_18","article-title":"Role of TGF-beta signaling in coupling bone remodeling","volume":"1344","author":"Crane","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-b signaling in cancer","volume":"3","author":"Colak","year":"2016","journal-title":"Trends Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022285","article-title":"TGF-beta, bone morphogenetic protein, and activin signaling and the tumor microenvironment","volume":"9","author":"Pickup","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri.2016.112","article-title":"Immunoregulation by members of the TGFbeta superfamily","volume":"16","author":"Chen","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGF\u03b2","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1158\/0008-5472.CAN-13-0987","article-title":"Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways","volume":"73","author":"Sawant","year":"2013","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mce.2016.11.025","article-title":"Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-beta in ovarian tumor cell lines","volume":"440","author":"Pazos","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41467-017-01500-9","article-title":"Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma","volume":"8","author":"Natsuizaka","year":"2017","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","article-title":"Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression","volume":"15","author":"Micalizzi","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1210\/er.2016-1002","article-title":"Notch signaling and the skeleton","volume":"37","author":"Zanotti","year":"2016","journal-title":"Endocr Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.18632\/oncotarget.2084","article-title":"Notch signaling drives multiple myeloma induced osteoclastogenesis","volume":"5","author":"Colombo","year":"2014","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"B54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2014.12.001","article-title":"Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment","volume":"41","author":"Criscitiello","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bonekey.2012.2","article-title":"Notch signaling: mediator and therapeutic target of bone metastasis","volume":"1","author":"Sethi","year":"2012","journal-title":"Bonekey Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/bju.12452","article-title":"Inflammation and prostate cancer: the role of interleukin 6 (IL-6)","volume":"113","author":"Nguyen","year":"2014","journal-title":"BJU Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1172\/JCI11089","article-title":"Interactions between immune and bone cells: new insights with many remaining questions","volume":"106","author":"Lorenzo","year":"2000","journal-title":"J Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.yexcr.2013.06.003","article-title":"Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6","volume":"319","author":"Lin","year":"2013","journal-title":"Exp Cell Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1038\/ncomms10442","article-title":"Self-renewal of CD133(hi) cells by IL6\/Notch3 signalling regulates endocrine resistance in metastatic breast cancer","volume":"7","author":"Sansone","year":"2016","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"56013","DOI":"10.18632\/oncotarget.10820","article-title":"Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche","volume":"7","author":"Colombo","year":"2016","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.18632\/oncotarget.3241","article-title":"Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6\/STAT3\/Jagged-1\/Notch positive feedback loop","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1634\/stemcells.2006-0442","article-title":"p66Shc\/Notch-3 interplay controls self-renewal and hypoxia survival in human stem\/progenitor cells of the mammary gland expanded in vitro as mammospheres","volume":"25","author":"Sansone","year":"2007","journal-title":"Stem Cells"},{"key":"B65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cas.13433","article-title":"Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity","volume":"109","author":"Tsukamoto","year":"2018","journal-title":"Cancer Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"26826","DOI":"10.18632\/oncotarget.5025","article-title":"Notch signaling deregulation in multiple myeloma: a rational molecular target","volume":"6","author":"Colombo","year":"2015","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12026-014-8528-x","article-title":"Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma","volume":"59","author":"Rosean","year":"2014","journal-title":"Immunol Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/s41467-017-01890-w","article-title":"Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma","volume":"8","author":"Lazzari","year":"2017","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/08830185.2015.1027629","article-title":"Targeting tumor initiating cells through inhibition of cancer testis antigens and Notch signaling: a hypothesis","volume":"34","author":"Colombo","year":"2015","journal-title":"Int Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/onc.2012.517","article-title":"Non-canonical Notch signaling activates IL-6\/JAK\/STAT signaling in breast tumor cells and is controlled by p53 and IKKalpha\/IKKbeta","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"key":"B73","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/onc.2008.379","article-title":"Rbpj conditional knockout reveals distinct functions of Notch4\/Int3 in mammary gland development and tumorigenesis","volume":"28","author":"Raafat","year":"2009","journal-title":"Oncogene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-14-0914","article-title":"Molecular pathways: targeting the CXCR4-CXCL12 Axis \u2013 untapped potential in the tumor microenvironment","volume":"21","author":"Scala","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pharmthera.2017.05.012","article-title":"Emerging roles of the CXCL12\/CXCR4 axis in pancreatic cancer progression and therapy","volume":"179","author":"Sleightholm","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/leu.2013.6","article-title":"Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes","volume":"27","author":"Colombo","year":"2013","journal-title":"Leukemia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3904\/kjim.2016.244","article-title":"Targeting the CXCL12\/CXCR4 axis in acute myeloid leukemia: from bench to bedside","volume":"32","author":"Cho","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ccell.2015.05.003","article-title":"CXCR4 is required for leukemia-initiating cell activity in T cell acute lymphoblastic leukemia","volume":"27","author":"Passaro","year":"2015","journal-title":"Cancer Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2016.09.002","article-title":"Tumor microenvironment-mediated chemoresistance in breast cancer","volume":"30","author":"velaei","year":"2016","journal-title":"Breast"},{"key":"B81","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/hep.27665","article-title":"CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/2326-6066.CIR-16-0303","article-title":"Increasing tumor-infiltrating T cells through inhibition of CXCL12 with NOX-A12 synergizes with PD-1 blockade","volume":"5","author":"Zboralski","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-017-0552-6","article-title":"Cancer immunotherapy beyond immune checkpoint inhibitors","volume":"11","author":"Marin-Acevedo","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"15993","DOI":"10.1074\/jbc.M901144200","article-title":"Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by Notch signaling through the up-regulation of CXCR4","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"E2911","DOI":"10.1073\/pnas.1702564114","article-title":"Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia","volume":"114","author":"Fabbri","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1189\/jlb.5MA0915-394R","article-title":"Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia","volume":"99","author":"Jost Tanja","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/path.3015","article-title":"Notch1 regulates chemotaxis and proliferation by controlling the chemokine receptors 5 and 9 in T-cell acute lymphoblastic leukemia","volume":"226","author":"Mirandola","year":"2012","journal-title":"J Pathol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","article-title":"Bone metastases: an overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol Rev"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/febs.13645","article-title":"RANK as a therapeutic target in cancer","volume":"283","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2016","journal-title":"FEBS J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.2174\/138945012802429615","article-title":"Overcoming drug resistance and treating advanced prostate cancer","volume":"13","author":"Semenas","year":"2012","journal-title":"Curr Drug Targets"},{"key":"B93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00223-016-0162-2","article-title":"Adipose, bone, and myeloma: contributions from the microenvironment","volume":"100","author":"McDonald","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1128\/MCB.00299-08","article-title":"The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis","volume":"28","author":"Fukushima","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional Notch signaling and osteocyte-derived factors in the bone marrow microenvironment promote tumor cell proliferation and bone destruction in multiple myeloma","volume":"76","author":"Delgado-Calle","year":"2016","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4161\/onci.1.2.18480","article-title":"Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer","volume":"1","author":"Zhao","year":"2012","journal-title":"Oncoimmunology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature09707","article-title":"Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling","volume":"470","author":"Tan","year":"2011","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20131889","article-title":"Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance","volume":"211","author":"Khan","year":"2014","journal-title":"J Exp Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/pcmr.12194","article-title":"Notch signaling in melanoma: interacting pathways and stromal influences that enhance Notch targeting","volume":"27","author":"Bedogni","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1158\/1078-0432.CCR-17-0606","article-title":"Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated antitumor immunity in mice","volume":"23","author":"Ahern","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","article-title":"The anti-tumor effect of RANKL inhibition in malignant solid tumors \u2013 a systematic review","volume":"62","author":"de Groot","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B102","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/CCO.0000000000000006","article-title":"Current status of interleukin-10 and regulatory T-cells in cancer","volume":"25","author":"Dennis","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0139598","DOI":"10.1371\/journal.pone.0139598","article-title":"Serum IL-10 predicts worse outcome in cancer patients: a meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/ni1102-999","article-title":"Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes","volume":"3","author":"Khong","year":"2002","journal-title":"Nat Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1158\/1078-0432.CCR-12-3439","article-title":"IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma","volume":"19","author":"Sung","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2003.11.001","article-title":"The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle","volume":"15","author":"Mocellin","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000067596","article-title":"The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells","volume":"129","author":"Levings","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/eji.1830270526","article-title":"Effect of interleukin-10 on dendritic cell maturation and function","volume":"27","author":"De Smedt","year":"1997","journal-title":"Eur J Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2567.2001.01235.x","article-title":"Mechanisms of interleukin-10-mediated immune suppression","volume":"103","author":"Akdis","year":"2001","journal-title":"Immunology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1084\/jem.180.6.2371","article-title":"Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression","volume":"180","author":"Matsuda","year":"1994","journal-title":"J Exp Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1158\/0008-5472.CAN-17-0740","article-title":"IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer","volume":"77","author":"Lamichhane","year":"2017","journal-title":"Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1158\/0008-5472.CAN-12-0721","article-title":"IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs","volume":"72","author":"Emmerich","year":"2012","journal-title":"Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G","article-title":"IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18","volume":"29","author":"Cai","year":"1999","journal-title":"Eur J Immunol"},{"key":"B115","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.154.9.4341","article-title":"The role of IL-10 in human B cell activation, proliferation, and differentiation","volume":"154","author":"Itoh","year":"1995","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-3-0348-0837-8_16","article-title":"The role of inflammation and liver cancer","volume":"816","author":"Bishayee","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2016.04.002","article-title":"Interleukin-4 receptor signaling and its binding mechanism: a therapeutic insight from inhibitors tool box","volume":"32","author":"Ul-Haq","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI28828","article-title":"Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells","volume":"116","author":"Gallina","year":"2006","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10585-015-9747-9","article-title":"Targeting IL4\/IL4R for the treatment of epithelial cancer metastasis","volume":"32","author":"Bankaitis","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00262-017-2043-6","article-title":"IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model","volume":"66","author":"Ito","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2567.2005.02168.x","article-title":"The phenotype of type 1 and type 2 CD8(+) T cells activated in vitro is affected by culture conditions and correlates with effector activity","volume":"115","author":"Kemp","year":"2005","journal-title":"Immunology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0092-8674(04)00451-9","article-title":"Instruction of distinct CD4 T helper cell fates by different Notch ligands on antigen-presenting cells","volume":"117","author":"Amsen","year":"2004","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.immuni.2006.04.009","article-title":"The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells","volume":"24","author":"Tanaka","year":"2006","journal-title":"Immunity"},{"key":"B124","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.18632\/oncotarget.3462","article-title":"CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition","volume":"6","author":"Long","year":"2015","journal-title":"Oncotarget"},{"key":"B125","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2567.2008.02845.x","article-title":"Control of IL-4 expression in T helper 1 and 2 cells","volume":"124","author":"Gilmour","year":"2008","journal-title":"Immunology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B127","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0171-2985(11)80543-7","article-title":"TNF-induced activation of NF-kappa B","volume":"193","author":"Schutze","year":"1995","journal-title":"Immunobiology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/clpt.2009.312","article-title":"Cancer and inflammation: implications for pharmacology and therapeutics","volume":"87","author":"Balkwill","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"B129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","article-title":"A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment","volume":"72","author":"Kulbe","year":"2012","journal-title":"Cancer Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.4049\/jimmunol.0902070","article-title":"TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function","volume":"184","author":"Nagar","year":"2010","journal-title":"J Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O\u2019Shea","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1158\/0008-5472.CAN-14-2956","article-title":"Aberrant expression of MHC class II in melanoma attracts inflammatory tumor-specific CD4+ T- cells, which dampen CD8+ T-cell antitumor reactivity","volume":"75","author":"Donia","year":"2015","journal-title":"Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1172\/JCI45797","article-title":"Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice","volume":"121","author":"Maniati","year":"2011","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2011.11.018","article-title":"IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression","volume":"45","author":"Liu","year":"2012","journal-title":"Mol Cell"},{"key":"B137","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1158\/0008-5472.CAN-17-0357","article-title":"Anti-jagged immunotherapy inhibits MDSCs and overcomes tumor-induced tolerance","volume":"77","author":"Sierra","year":"2017","journal-title":"Cancer Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"B139","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","article-title":"Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17","volume":"22","author":"Stark","year":"2005","journal-title":"Immunity"},{"key":"B141","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","article-title":"Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis","volume":"169","author":"Starnes","year":"2002","journal-title":"J Immunol"},{"key":"B142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B143","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J Immunol"},{"key":"B144","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.4049\/jimmunol.162.9.5337","article-title":"NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells","volume":"162","author":"Awane","year":"1999","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cyto.2015.09.011","article-title":"Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis","volume":"89","author":"Qian","year":"2017","journal-title":"Cytokine"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/ijms17091433","article-title":"Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type","volume":"17","author":"Fabre","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1476-4598-10-150","article-title":"IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma","volume":"10","author":"Gu","year":"2011","journal-title":"Mol Cancer"},{"key":"B148","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma","volume":"115","author":"Prabhala","year":"2010","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","article-title":"Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis","volume":"41","author":"Wang","year":"2014","journal-title":"Immunity"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nm.3291","article-title":"An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy","volume":"19","author":"Chung","year":"2013","journal-title":"Nat Med"},{"key":"B151","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells","volume":"184","author":"He","year":"2010","journal-title":"J Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e8922","DOI":"10.1371\/journal.pone.0008922","article-title":"Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS One"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","article-title":"Interleukin-17 promotes angiogenesis and tumor growth","volume":"101","author":"Numasaki","year":"2003","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11102-011-0292-5","article-title":"The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas","volume":"14","author":"Qiu","year":"2011","journal-title":"Pituitary"},{"key":"B156","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7150\/ijbs.7.53","article-title":"Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients","volume":"7","author":"Chen","year":"2011","journal-title":"Int J Biol Sci"},{"key":"B157","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/CJI.0b013e3182a802cf","article-title":"IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival","volume":"36","author":"Lu","year":"2013","journal-title":"J Immunother"},{"key":"B158","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3324\/haematol.2011.047316","article-title":"Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance","volume":"97","author":"Jain","year":"2012","journal-title":"Haematologica"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"B160","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00262-015-1678-4","article-title":"FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma","volume":"64","author":"Punt","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B161","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12094-014-1197-3","article-title":"Interleukin-17 is a favorable prognostic marker for colorectal cancer","volume":"17","author":"Lin","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood.V99.6.2114","article-title":"Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism","volume":"99","author":"Benchetrit","year":"2002","journal-title":"Blood"},{"key":"B163","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.0804322","article-title":"Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation","volume":"182","author":"Mukherjee","year":"2009","journal-title":"J Immunol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"B165","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4049\/jimmunol.1003658","article-title":"Notch signaling regulates mouse and human Th17 differentiation","volume":"187","author":"Keerthivasan","year":"2011","journal-title":"J Immunol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.4049\/jimmunol.181.12.8189","article-title":"Cutting edge: Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production","volume":"181","author":"Bugeon","year":"2008","journal-title":"J Immunol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.exphem.2006.04.027","article-title":"Delta-4 expression on a stromal cell line is augmented by interleukin-6 via STAT3 activation","volume":"34","author":"Suzuki","year":"2006","journal-title":"Exp Hematol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.18632\/oncotarget.13051","article-title":"gammadelta T cells in cancer immunotherapy","volume":"8","author":"Zou","year":"2017","journal-title":"Oncotarget"},{"key":"B169","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.trecan.2017.06.003","article-title":"\u03b3\u03b4 T cells: unexpected regulators of cancer development and progression","volume":"3","author":"Fleming","year":"2017","journal-title":"Trends Cancer"},{"key":"B170","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fimmu.2015.00037","article-title":"The Jekyll and Hyde story of IL17-Producing \u03b3\u03b4T Cells","volume":"6","author":"Patil","year":"2015","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.modgep.2005.04.004","article-title":"Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles","volume":"5","author":"Benedito","year":"2005","journal-title":"Gene Expr Patterns"},{"key":"B172","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/15384047.2017.1373219","article-title":"Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5\/CCR5 axis","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B173","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","article-title":"Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity","volume":"377","author":"De Veirman","year":"2016","journal-title":"Cancer Lett"},{"key":"B174","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","article-title":"The inflammatory chemokine CCL5 and cancer progression","volume":"2014","author":"Aldinucci","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B176","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","article-title":"T cell metabolic fitness in antitumor immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/1078-0432.CCR-05-1603","article-title":"The role of interleukin 1 in growth and metastasis of human cancer xenografts","volume":"12","author":"Elaraj","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B178","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B179","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.mce.2013.03.025","article-title":"Leptin-cytokine crosstalk in breast cancer","volume":"382","author":"Newman","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","article-title":"The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions","volume":"25","author":"Apte","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3892\/ijo.2014.2809","article-title":"Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role","volume":"46","author":"Zhang","year":"2015","journal-title":"Int J Oncol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J Exp Med"},{"key":"B184","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1209171109","article-title":"Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis","volume":"109","author":"Drexler","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B185","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","article-title":"Inflammation-related IL1beta\/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma","volume":"9","author":"Kadariya","year":"2016","journal-title":"Cancer Prev Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","article-title":"Targeting inflammasome\/IL-1 pathways for cancer immunotherapy","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"B187","first-page":"4625","article-title":"Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma","volume":"56","author":"Leek","year":"1996","journal-title":"Cancer Res"},{"key":"B188","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/ijc.28496","article-title":"Obesity induced a leptin-Notch signaling axis in breast cancer","volume":"134","author":"Battle","year":"2014","journal-title":"Int J Cancer"},{"key":"B190","doi-asserted-by":"publisher","first-page":"e21467","DOI":"10.1371\/journal.pone.0021467","article-title":"Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF\/VEGFR-2 expression in breast cancer","volume":"6","author":"Guo","year":"2011","journal-title":"PLoS One"},{"key":"B191","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5662\/wjm.v6.i1.43","article-title":"Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer","volume":"6","author":"Lipsey","year":"2016","journal-title":"World J Methodol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/emmm.201201623","article-title":"Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain","volume":"5","author":"Xing","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B193","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-385071-3.00003-4","article-title":"Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic","volume":"95","author":"Zhang","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.ajpath.2016.03.010","article-title":"Delta-like ligand 4 modulates liver damage by down-regulating chemokine expression","volume":"186","author":"Shen","year":"2016","journal-title":"Am J Pathol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bbrc.2008.05.079","article-title":"Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells","volume":"372","author":"Kang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B196","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The roles of IFN gamma in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"B198","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2013.07.006","article-title":"Notch simultaneously orchestrates multiple helper T cell programs independently of cytokine signals","volume":"39","author":"Bailis","year":"2013","journal-title":"Immunity"},{"key":"B199","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1074\/jbc.M113.519686","article-title":"Novel regulation of CD80\/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells","volume":"289","author":"Koorella","year":"2014","journal-title":"J Biol Chem"},{"key":"B200","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1182\/blood-2012-07-442962","article-title":"Notch controls generation and function of human effector CD8+ T cells","volume":"121","author":"Kuijk","year":"2013","journal-title":"Blood"},{"key":"B201","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ni1209","article-title":"Inhibitors of \u03b3-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21","volume":"6","author":"Minter","year":"2005","journal-title":"Nat Immunol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood-2008-03-144980","article-title":"Notch1 and TGF\u03b21 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells","volume":"112","author":"Samon","year":"2008","journal-title":"Blood"},{"key":"B203","doi-asserted-by":"publisher","first-page":"14747","DOI":"10.1073\/pnas.0507355102","article-title":"Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum","volume":"102","author":"Baratin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ni1244","article-title":"Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity","volume":"6","author":"Andoniou","year":"2005","journal-title":"Nat Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood-2004-11-4237","article-title":"Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines","volume":"105","author":"DeHart","year":"2005","journal-title":"Blood"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1182\/blood-2004-08-3257","article-title":"Notch ligands Delta1 and Jagged1 transmit distinct signals to T-cell precursors","volume":"105","author":"Lehar","year":"2005","journal-title":"Blood"},{"key":"B207","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.4049\/jimmunol.0802598","article-title":"Notch regulates cytolytic effector function in CD8+ T cells","volume":"182","author":"Cho","year":"2009","journal-title":"J Immunol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1084\/jem.20050923","article-title":"Notch signaling is an important regulator of type 2 immunity","volume":"202","author":"Tu","year":"2005","journal-title":"J Exp Med"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1084\/jem.20062305","article-title":"CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS","volume":"204","author":"Skokos","year":"2007","journal-title":"J Exp Med"},{"key":"B210","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"B211","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4161\/org.4.4.7414","article-title":"VEGF and endothelial guidance in angiogenic sprouting","volume":"4","author":"Gerhardt","year":"2008","journal-title":"Organogenesis"},{"key":"B212","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","article-title":"Angiogenesis: a team effort coordinated by Notch","volume":"16","author":"Phng","year":"2009","journal-title":"Dev Cell"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/1947601911423030","article-title":"Notch signaling in developmental and tumor angiogenesis","volume":"2","author":"Kofler","year":"2011","journal-title":"Genes Cancer"},{"key":"B214","doi-asserted-by":"publisher","first-page":"E3836","DOI":"10.1073\/pnas.1511814112","article-title":"Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision","volume":"112","author":"Boareto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B215","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ccr.2014.02.005","article-title":"Angiocrine factors deployed by tumor vascular niche induce B-cell lymphoma invasiveness and chemoresistance","volume":"25","author":"Cao","year":"2014","journal-title":"Cancer Cell"},{"key":"B216","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccell.2017.01.007","article-title":"Endothelial Notch1 activity facilitates metastasis","volume":"31","author":"Wieland","year":"2017","journal-title":"Cancer Cell"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1158\/0008-5472.CAN-08-2791","article-title":"Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy","volume":"69","author":"Indraccolo","year":"2009","journal-title":"Cancer Res"},{"key":"B218","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B219","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","article-title":"Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer","volume":"31","author":"Masoumi Moghaddam","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"key":"B222","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri3064","article-title":"The parallel lives of angiogenesis and immunosuppression: cancer and other tales","volume":"11","author":"Motz","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","article-title":"T-regulatory cells: key players in tumor immune escape and angiogenesis","volume":"72","author":"Facciabene","year":"2012","journal-title":"Cancer Res"},{"key":"B224","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.seminoncol.2014.02.007","article-title":"Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond","volume":"41","author":"Mittal","year":"2014","journal-title":"Semin Oncol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1158\/0008-5472.CAN-07-0969","article-title":"Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","article-title":"Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis","volume":"444","author":"Noguera-Troise","year":"2006","journal-title":"Nature"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nature05313","article-title":"Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis","volume":"444","author":"Ridgway","year":"2006","journal-title":"Nature"},{"key":"B228","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","article-title":"NOTCH decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth","volume":"5","author":"Kangsamaksin","year":"2015","journal-title":"Cancer Discov"},{"key":"B229","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1158\/1078-0432.CCR-11-0432","article-title":"Targeting the Notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer","volume":"17","author":"Steg","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B230","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccr.2005.06.004","article-title":"Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling","volume":"8","author":"Zeng","year":"2005","journal-title":"Cancer Cell"},{"key":"B231","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1158\/0008-5472.CAN-07-6499","article-title":"A Notch1 ectodomain construct inhibits endothelial Notch signaling, tumor growth, and angiogenesis","volume":"68","author":"Funahashi","year":"2008","journal-title":"Cancer Res"},{"key":"B232","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1172\/JCI24311","article-title":"Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression","volume":"117","author":"Shawber","year":"2007","journal-title":"J Clin Invest"},{"key":"B233","first-page":"2681","article-title":"Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition nuclear factor-kappaB signaling","volume":"8","author":"Liu","year":"2016","journal-title":"Am J Transl Res"},{"key":"B234","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/01.sla.0000189115.94847.f1","article-title":"The Notch signaling pathway is related to neurovascular progression of pancreatic cancer","volume":"242","author":"Buchler","year":"2005","journal-title":"Ann Surg"},{"key":"B235","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1182\/blood-2003-12-4114","article-title":"Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines","volume":"104","author":"Houde","year":"2004","journal-title":"Blood"},{"key":"B236","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/mc.22440","article-title":"Multiple myeloma cells modify VEGF\/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch\/miR-223","volume":"55","author":"Berenstein","year":"2016","journal-title":"Mol Carcinog"},{"key":"B237","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-824X-4-7","article-title":"Notch signals in the endothelium and cancer \u201cstem-like\u201d cells: opportunities for cancer therapy","volume":"4","author":"Gu","year":"2012","journal-title":"Vasc Cell"},{"key":"B238","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2174\/156652409788970634","article-title":"Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression","volume":"9","author":"Johnson","year":"2009","journal-title":"Curr Mol Med"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"key":"B240","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000086784","article-title":"Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings","volume":"68","author":"Della Porta","year":"2005","journal-title":"Oncology"},{"key":"B241","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00262-003-0466-8","article-title":"Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines","volume":"53","author":"Takahashi","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"B242","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00262-007-0441-x","article-title":"The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients","volume":"57","author":"Osada","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"B243","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.160.3.1224","article-title":"Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells","volume":"160","author":"Oyama","year":"1998","journal-title":"J Immunol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2002-07-1956","article-title":"VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression","volume":"101","author":"Ohm","year":"2003","journal-title":"Blood"},{"key":"B245","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1084\/jem.20111497","article-title":"Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth","volume":"209","author":"Hansen","year":"2012","journal-title":"J Exp Med"},{"key":"B246","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res"},{"key":"B247","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00008390-200510000-00010","article-title":"Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A","volume":"15","author":"Varney","year":"2005","journal-title":"Melanoma Res"},{"key":"B248","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.3989","article-title":"Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages","volume":"227","author":"Linde","year":"2012","journal-title":"J Pathol"},{"key":"B249","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"key":"B250","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J Exp Med"},{"key":"B251","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"B252","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm863","article-title":"Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity","volume":"9","author":"Curiel","year":"2003","journal-title":"Nat Med"},{"key":"B253","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/icb.2012.53","article-title":"Notch signaling regulates PD-1 expression during CD8(+) T-cell activation","volume":"91","author":"Mathieu","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"B254","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/JCI20784","article-title":"Cellular senescence in cancer treatment: friend or foe?","volume":"113","author":"Kahlem","year":"2004","journal-title":"J Clin Invest"},{"key":"B255","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","article-title":"Inflammatory networks during cellular senescence: causes and consequences","volume":"16","author":"Freund","year":"2010","journal-title":"Trends Mol Med"},{"key":"B256","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ncb3397","article-title":"NOTCH1 mediates a switch between two distinct secretomes during senescence","volume":"18","author":"Hoare","year":"2016","journal-title":"Nat Cell Biol"},{"key":"B257","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1158\/0008-5472.CAN-12-3902","article-title":"Notch3 functions as a tumor suppressor by controlling cellular senescence","volume":"73","author":"Cui","year":"2013","journal-title":"Cancer Res"},{"key":"B258","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/onc.2014.169","article-title":"Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor suppressor activities","volume":"34","author":"Kagawa","year":"2015","journal-title":"Oncogene"},{"key":"B259","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00262-012-1318-1","article-title":"A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response","volume":"62","author":"Kang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B260","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.1523\/JNEUROSCI.0353-12.2012","article-title":"TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity","volume":"32","author":"Blouet","year":"2012","journal-title":"J Neurosci"},{"key":"B261","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ncb3228","article-title":"Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation","volume":"17","author":"Procopio","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B262","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res"},{"key":"B263","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-12-4150","article-title":"Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma","volume":"73","author":"Costea","year":"2013","journal-title":"Cancer Res"},{"key":"B264","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1158\/0008-5472.CAN-10-0673","article-title":"Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations","volume":"70","author":"Hosein","year":"2010","journal-title":"Cancer Res"},{"key":"B265","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1073\/pnas.1014506108","article-title":"Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer","volume":"108","author":"Navab","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B266","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1200\/JCO.2016.34.15_suppl.4070","article-title":"A phase 2 study of galunisertib, a novel transforming growth factor-beta (TGF-\u03b2) receptor I kinase inhibitor, in patients with advanced hepatocellular carcinoma (HCC) and low serum alpha fetoprotein (AFP)","volume":"34","author":"Faivre","year":"2016","journal-title":"J Clin Oncol"},{"key":"B267","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1200\/JCO.2016.34.15_suppl.4019","article-title":"A phase II, double-blind study of galunisertib+gemcitabine (GG) vs gemcitabine+placebo (GP) in patients (pts) with unresectable pancreatic cancer (PC)","volume":"34","author":"Melisi","year":"2016","journal-title":"J Clin Oncol"},{"key":"B268","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejca.2011.10.014","article-title":"Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone\/prednisone versus mitoxantrone\/prednisone alone in metastatic castration-resistant prostate cancer","volume":"48","author":"Fizazi","year":"2012","journal-title":"Eur J Cancer"},{"key":"B269","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B270","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajh.23868","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma","volume":"90","author":"Orlowski","year":"2015","journal-title":"Am J Hematol"},{"key":"B271","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1038\/bcj.2016.4","article-title":"Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial","volume":"6","author":"Shah","year":"2016","journal-title":"Blood Cancer J"},{"key":"B272","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00277-018-3229-5","article-title":"A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia","volume":"97","author":"Martinez-Cuadron","year":"2018","journal-title":"Ann Hematol"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26414","article-title":"A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: a Pediatric Oncology Experimental Therapeutics Investigators\u2019 Consortium study (POE 10-03)","volume":"64","author":"Cooper","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B274","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/annonc\/mdn054","article-title":"A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer","volume":"19","author":"Brown","year":"2008","journal-title":"Ann Oncol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","article-title":"A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors","volume":"71","author":"Sandhu","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"B276","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"key":"B277","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cdtm.2017.01.002","article-title":"Revision of the concept of anti-angiogenesis and its applications in tumor treatment","volume":"3","author":"Yang","year":"2017","journal-title":"Chronic Dis Transl Med"},{"key":"B278","doi-asserted-by":"publisher","first-page":"E1786","DOI":"10.3390\/ijms18081786","article-title":"A review of anti-angiogenic targets for monoclonal antibody cancer therapy","volume":"18","author":"Kong","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B279","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"key":"B280","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of Notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol Sci"},{"key":"B281","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/leu.2013.183","article-title":"Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts","volume":"28","author":"Agnusdei","year":"2014","journal-title":"Leukemia"},{"key":"B282","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-14-2808","article-title":"Targeting Notch signaling with a Notch2\/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency","volume":"21","author":"Yen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B283","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1158\/1078-0432.CCR-14-1373","article-title":"A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors","volume":"20","author":"Smith","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B284","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.4049\/jimmunol.179.9.5990","article-title":"JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis","volume":"179","author":"Elyaman","year":"2007","journal-title":"J Immunol"},{"key":"B285","doi-asserted-by":"publisher","first-page":"e0182640","DOI":"10.1371\/journal.pone.0182640","article-title":"Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening","volume":"12","author":"Platonova","year":"2017","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T09:59:36Z","timestamp":1693821576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":285,"alternative-id":["10.3389\/fimmu.2018.01823"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01823","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"article-number":"1823"}}